New cardiotonic agents — a promising approach for treatment of heart failure
- 31 May 1988
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 9 (5), 166-170
- https://doi.org/10.1016/0165-6147(88)90031-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long-term oral enoximone therapy in chronic cardiac failureThe American Journal of Cardiology, 1987
- Influence of association and of positive inotropic drugs on calcium binding to cardiac troponin CBiochemical and Biophysical Research Communications, 1987
- Ca2+-sensitizing effect of BM 14.478 on skinned cardiac muscle fibres of guinea-pig papillary muscleEuropean Journal of Pharmacology, 1987
- Contractile proteins: possible targets for the cardiotonic action of MCI-154 a novel cardiotonic agent?European Journal of Pharmacology, 1987
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Effect of xamoterol (ICI 118587), a new beta1 adrenoceptor partial agonist, on resting haemodynamic variables and exercise tolerance in patients with left ventricular dysfunction.Heart, 1985
- Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failureJournal of Medicinal Chemistry, 1984
- Pharmacology and inotropic potential of forskolin in the human heart.Journal of Clinical Investigation, 1984
- Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure.Circulation, 1984
- Acute inotropic stimulation with dopamine in severe congestive heart failure: Beneficial hemodynamic effect at rest but not during maximal exerciseThe American Journal of Cardiology, 1983